title: SOP 05: Patient information and informed consent.
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence / Q000592:standards*; D015507:Drugs, Investigational / Q000009:adverse effects / Q000627:therapeutic use*; D005060:Europe; D005568:Forms and Records Control / Q000331:legislation & jurisprudence / Q000592:standards; D019983:Guideline Adherence / Q000331:legislation & jurisprudence / Q000592:standards; D006801:Humans; D007258:Informed Consent / Q000331:legislation & jurisprudence / Q000592:standards*; D019458:Insurance Coverage / Q000331:legislation & jurisprudence / Q000592:standards; D009369:Neoplasms / Q000188:drug therapy*; D010353:Patient Education as Topic / Q000331:legislation & jurisprudence / Q000592:standards*
chemical_list: D000970:Antineoplastic Agents; D015507:Drugs, Investigational